Nonfatal Overdoses in Emergency Departments: Bridging Patient Characteristics, Biospecimen Toxicology, and Drug Supply Composition

Office of National Drug Control Policy · United States government procurement

Closed August 31, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

This research project will help build local and national drug consumption surveillance, identify gaps in existing drug testing protocols, facilitate information exchange across public health and public safety organizations, and help coordinate an informed response to address the drug crisis.

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyOffice of National Drug Control Policy
CountryUnited States
CategoryPharmaceuticals
PublishedAugust 12, 2026
Procurement stageActive solicitation
ClosedAugust 31, 2026
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: U.S. Government (Grants.gov) — public domain. Not affiliated with or endorsed by the United States Government.

Browse Similar Open Opportunities in United States

OJJDP FY 2026 Community and Schools Youth Drug Prevention Program
OJJDP FY 2026 Juvenile Drug Treatment Court Program
2027 Southern Hemisphere Influenza Vaccine
Multiple Award Schedule
Multiple Award Schedule
PPVG GEN V Award
Fiscal Year 2027 State Workforce Agency Unemployment Insurance Resource Planning Targets and Guidelines
Advancing Global Health

See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Pharmaceuticals intelligence report in your inbox

A personalized report on United States Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.